Blood Cancer

August 15, 2022

For almost all the patients with stage I or stage II disease, the cumulative incidence of CVD mortality exceeded that of classical Hodgkin lymphoma and other cancers, according to research results published in the journal Cancer.

August 15, 2022

The researchers attributed low adherence to oral anti-cancer medications for blood cancer and certain other cancers to high monthly out-of-pocket among several other reasons.

August 12, 2022

Researchers report that half of the online pharmacies are rogue operations that may operate without a license or have other serious shortcomings.

July 13, 2022

MD Anderson’s Patrick Reville says preclinical research shows combining CAR-T therapy with other treatments may make it more effective as treatment for large B cell lymphomas.

July 13, 2022

The FDA has approved two CAR-T therapies and a review of bispecific antibody is underway.

July 12, 2022

Results show that the mortality risk was cut in half for patients who got help with the financial burden of their care. Quality of life scores also improved.

September 17, 2021

An Ibrance-Jakafi combination shows promise in a mouse model of myelofibrosis.

September 06, 2021

Lack of antibodies from vaccination mainly affects patients with B cell cancers. Experts say antibodies are just one piece of the puzzle and that other aspects of the immune system fend off serious cases of COVID-19.

August 13, 2021

The confirmatory trial of one of the approved drugs, Pepaxto, was halted when data suggested it was associated with a higher mortality rate.

August 10, 2021

NCCN adds Rylaze to guidelines soon after was approved by the FDA and a British company reports positive results for its CAR-T therapy.